"Drug Development - Womans Diagnostics and Treatments - Medical Marijuana - High Growth Industries and Sectors"

Easton Pharmaceuticals

Latest Company Advancements

Exclusive Distributorship Agreement With Multi-National Gideon Richter Finalized



Easton Pharmaceuticals / BMV Medica Have Finalized a Joint Partnership Agreement With Multi-National Pharmaceutical Company Gideon Richter For Its Woman's Gynofit Product For The Treatment Of BV (Bacterial Vaginosis) for the Country Of Mexico

Easton Pharmaceuticals Inc. and partner BMV Medica has signed a Sales & Marketing Agreement with Gedeon Richter Mexico S.A.P.I. de C.V. a Mexican-based company and affiliate of Gedeon Richter Plc, for Easton / BMV's "Gynofit" Lactic Acid Gel for the treatment of Bacterial Vaginosis for the country of Mexico.


Read More here

Revised Featured Products

Skin Renou HA Bottle Thin
Easton Pharmaceuticals is pleased to announce Skin Renou HA, Anti-aging Moisturizer.

Skin Renou HA is our newest Hyaluronic Acid fortified restorative moisturizer with active anti-aging ingredients. Skin Renou is an all natural moisturizer and contains No Parabans, Harsh Chemicals or Colorants.

BioLyse Pharma Cancer Drugs Distribution Agreement

Easton Pharmaceuticals

Easton Pharmaceuticals and BMV Medica Close on Joint Distribution Agreement for Injectable Approved Cancer Drugs for Mexico and Other Latin American Countries With Biolyse Pharma Corporation. Read 

Negotiations Towards Acqusitions

Easton Pharmaceuticals has entered into negotiations with 2 revenue generating companies towards the acquisition of one or both companies. Updates expected shortly...

Committed to Providing Safe and Effective Products

Our Mission

To engage in developing and acquiring drugs, diagnostics and treatment remedy products to build shareholder value. To provide products in many world jurisdictions for safe, effective and proven products to improve the health and well being of men and women. To build and capitalize on future fast growing industrys such as medical marijuana, vaporizers, e-liquids and other related sectors.  

Easton is re-initiating its efforts towards a patent pending on its minority interest in cancer drug "Xilive" based on in-house (non FDA approved) encouraging survival data from two late-stage, long-term cancer survivors who have been on Xilive for several years each. For More Information Visit Here

Financing Updates

Easton Pharmaceuticals has entered into discussions and has received proposals for financing required for corporate and other business expenses that are based around private placements for equity or on a convertible loan basis.